• Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study 

      Agüera Jorge, Marta; Soler-Garcia, Aleix; Alejandre, Carme; Moussalam-Merino, Sara; Sala-Castellvi, Pere; Pons Tomas, Gemma; Penela-Sánchez, Daniel; González-Grado, Carla; Alsina-Rossell, Judit; Climent, Carme; Esteva Afonso, Cristina; Fortuny, Clàudia; de Sevilla, Mariona F; Garcia-Garcia, Juan José; Brotons de los Reyes, Pedro; Balaguer, Albert; Estrada, Josep; Jordan, Iolanda; Muñoz-Almagro, Carmen; Launes, Cristian (Pediatric Allergy and Immunology, 2024)
      Background: Several clinical trials have shown that nirsevimab, an antibody targeting the respiratory syncytial virus (RSV), reduces RSV bronchiolitis requiring admission. In 2023–2024, Catalonia and ...